NEWS

RESVINET Meeting report has been Published

We are delighted to inform you that the report of our successful ReSViNET meeting in Zeist (2-3 March 2016) is published in “Journal of Global Health”. We invite you to read the full report by downloading the file via the link below.
resvinet_2016_meeting_report.pdf
File Size: 1515 kb
File Type: pdf
Download File

ThE RESVINET SCALE: a New Clinical Scale for Infants with Acute Respiratory Infection

We are very proud to announce that our board member, Dr. Federico Martinón Torres and his team, designed a new clinical scale for infants with acute respiratory infection, the ReSVinet scale. Our scale is based on seven parameters (feeding intolerance, medical intervention, respiratory difficulty, respiratory frequency, apnoea, general condition, fever) that were assigned different values (from 0 to 3) for a total of 20 points. 170 children under two years of age with ARI were assessed independently by three pediatricians using this scale. 

​We invite you to read the full report by downloading the file via the link below
Mortality due to respiratory syncytial virus: burden and risk factors

Sarah Geoghegan 1*; Anabella Erviti 1*; Mauricio T. Caballero 1*; Fernando Vallone 2; Stella M. Zanone 1; Juan Ves Losada 3; Alejandra Bianchi 1; Patricio L. Acosta 1; Laura B. Talarico 1; Adrian Ferretti 1; Luciano Alva Grimaldi 4; Andrea Sancilio 5; Karina Dueñas 5; Gustavo Sastre 6; Andrea Rodriguez 6; Fernando Ferrero 7; Edgar Barboza 8; Guadalupe Fernández Gago 9; Celina Nocito 10, Edgardo Flamenco 11; Alberto Rodriguez Perez 12; Beatriz Rebec 13; F. Martin Ferolla 1; Romina Libster 1; Ruth A. Karron 14; Eduardo Bergel 1; Fernando P. Polack 1,15.

ReSViNET sites

about REsvinet

RSV (Respiratory Syncytial Virus) infection is the second most important cause of death during infancy, especially in developing countries. RSV infection has also been linked to an increased risk in the development of chronic airway disease in later life. Therefore, research on RSV is crucial.

In order to improve research on RSV, ReSViNET (Respiratory Syncytial Virus Network) has been established. In this network, expertise and leadership are combined in order to decrease the global burden of RSV. It is our goal to improve knowledge of RSV epidemiology and to develop safe and effective therapeutic and preventive interventions.
Click here to learn more about ReSViNET